| scholarly article | Q13442814 |
| P50 | author | Anna N. A. Tosteson | Q110143968 |
| P2093 | author name string | Tor D Tosteson | |
| Qianfei Wang | |||
| Robert Cantu | |||
| John-Erik Bell | |||
| Julie P W Bynum | |||
| Jeffrey C Munson | |||
| Christine McDonough | |||
| P2860 | cites work | Use of inhaled corticosteroids and the risk of fracture. | Q51931278 |
| Cognitive impairment, drug use, and the risk of hip fracture in persons over 75 years old: a community-based prospective study. | Q51990035 | ||
| Second Hip Fracture in Older Men and Women | Q54877438 | ||
| Fracture risk with intermittent high-dose oral glucocorticoid therapy | Q57086741 | ||
| Oral corticosteroids and fracture risk: relationship to daily and cumulative doses | Q57086777 | ||
| Benzodiazepines and the risk of falls in nursing home residents. | Q64901469 | ||
| Subsequent hip fracture among older adults | Q72127990 | ||
| Fracture risk associated with inhaled corticosteroid use in chronic obstructive pulmonary disease | Q75230554 | ||
| Underuse of osteoporosis medications in elderly patients with fractures | Q79155890 | ||
| Anxiolytics, sedatives, antidepressants, neuroleptics and the risk of fracture | Q82747349 | ||
| Alendronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women | Q24242258 | ||
| Etidronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women | Q24242665 | ||
| Risedronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women | Q24242674 | ||
| The contribution of hip fracture to risk of subsequent fractures: data from two longitudinal studies | Q30881703 | ||
| Quality of osteoporosis care of older Medicare recipients with fragility fractures: 2006 to 2010. | Q33854982 | ||
| Outcomes and secondary prevention strategies for male hip fractures | Q34509405 | ||
| Effect of selective serotonin reuptake inhibitors on the risk of fracture | Q34574255 | ||
| Rosiglitazone-associated fractures in type 2 diabetes: an Analysis from A Diabetes Outcome Progression Trial (ADOPT). | Q34587610 | ||
| Long-term proton pump inhibitor therapy and risk of hip fracture | Q34595049 | ||
| Electronic surveillance and pharmacist intervention for vulnerable older inpatients on high-risk medication regimens | Q35109432 | ||
| Practice patterns in the diagnosis and treatment of osteoporosis after a fragility fracture: a systematic review | Q35838915 | ||
| Association between SSRI use and hip fractures and the effect of residual confounding bias in claims database studies | Q35945771 | ||
| Opioid Analgesics and the Risk of Hip Fracture in the Elderly: Codeine and Propoxyphene | Q36295916 | ||
| Fragility fractures and the osteoporosis care gap: an international phenomenon. | Q36449722 | ||
| Factors associated with a second hip fracture: a systematic review. | Q37023421 | ||
| Development of the Tool to Reduce Inappropriate Medications (TRIM): A Clinical Decision Support System to Improve Medication Prescribing for Older Adults | Q37033731 | ||
| Second fractures among older adults in the year following hip, shoulder, or wrist fracture | Q37224747 | ||
| Meta-analysis of the impact of 9 medication classes on falls in elderly persons | Q37637615 | ||
| Forecasting the burden of future postmenopausal hip fractures | Q39167280 | ||
| Psychotropic medications and the risk of fracture: a meta-analysis | Q40248718 | ||
| Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025. | Q40263627 | ||
| Rates of Deintensification of Blood Pressure and Glycemic Medication Treatment Based on Levels of Control and Life Expectancy in Older Patients With Diabetes Mellitus. | Q40391986 | ||
| A meta-analysis of previous fracture and subsequent fracture risk | Q40494142 | ||
| Central nervous system-active medications and risk for falls in older women | Q40628780 | ||
| Drugs and falls in older people: a systematic review and meta-analysis: I. Psychotropic drugs. | Q40827242 | ||
| Radial and humeral fractures as predictors of subsequent hip, radial or humeral fractures in women, and their seasonal variation | Q41080582 | ||
| Psychotropic drug use and the risk of hip fracture | Q41343137 | ||
| Thiazolidinediones and fractures in men and women | Q43295115 | ||
| Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: report from the National Osteoporosis Foundation | Q43583991 | ||
| Hip fracture patients at risk of second hip fracture: a nationwide population-based cohort study of 169,145 cases during 1977-2001. | Q45003700 | ||
| The risk of nonvertebral fracture related to inhaled corticosteroid exposure among adults with chronic respiratory disease | Q45226812 | ||
| Treatment with fall-risk-increasing and fracture-preventing drugs before and after a hip fracture: an observational study | Q45251758 | ||
| Risk of hip/femur fractures in patients using antipsychotics | Q46660140 | ||
| Occurrence and incidence of the second hip fracture. | Q51058217 | ||
| P433 | issue | 10 | |
| P304 | page(s) | 1531-1538 | |
| P577 | publication date | 2016-08-22 | |
| P1433 | published in | JAMA Internal Medicine | Q177428 |
| P1476 | title | Patterns of Prescription Drug Use Before and After Fragility Fracture | |
| P478 | volume | 176 |
| Q37653413 | Baseline Characteristics and Changes in Bone Mineral Density T-Scores of Bulgarian Women with Postmenopausal Osteoporosis Receiving Denosumab in Routine Clinical Practice |
| Q48243955 | Comorbidities and medication use in patients with a recent clinical fracture at the Fracture Liaison Service. |
| Q51758341 | Epidemiology of hip fracture in nursing home residents with multiple sclerosis. |
| Q33845318 | Falls-Related Drug Use and Risk of Falls Among Older Adults: A Study in a US Medicare Population |
| Q30235569 | Imminent fracture risk |
| Q64122011 | Impact of prescription drugs on second fragility fractures among US Medicare patients |
| Q92030236 | Joint effects of advancing age and number of potentially inappropriate medication classes on risk of falls in Medicare enrollees |
| Q64114614 | Patterns of Opioid Use in the 12 Months Following Geriatric Fragility Fractures: A Population-Based Cohort Study |
| Q44351276 | Persistence of Opioid Prescribing after a Forearm or Lower Leg Fracture |
| Q43075772 | Polypharmacy and risk of falls and fractures for patients with HIV infection and substance dependence. |
| Q98164946 | Postacute Management of Older Adults Suffering an Osteoporotic Hip Fracture: A Consensus Statement From the International Geriatric Fracture Society |
| Q47654343 | Potentially Inappropriate Medications and the Time to Full Functional Recovery After Hip Fracture. |
| Q51766035 | The Association between Anticholinergic Drug Use and Rehabilitation Outcome in Post-Acute Hip Fractured Patients: A Retrospective Cohort Study. |
Search more.